"iodine quantification may improve characterisation of portal vein thrombi during the late hepatic arterial phase especially in patients with hepatocellular carcinoma 19."
"dual-energy post-processing has potential to significantly increase contrast-to-noise ratio and the sensitivity for the diagnosis of venous thrombosis 20."
"dual-energy post-processing has potential to significantly increase contrast-to-noise ratio and the sensitivity for the diagnosis of venous thrombosis 20."
"beware slow or turbulent flow artefacts"
"beware slow flow-related artefacts"
"18F-FDG PET-CT has demonstrated a promising ability to differentiate between bland thrombus and malignant (tumour thrombus) portal vein thrombosis 5-11. The optimal imaging protocol appears to be with hybrid imaging part state-of-the-art CT including IV iodinated contrast media 10. Demonstrated features are:"
"The demographics of patients with portal venous thrombosis will match those of the underlying condition. The prevalence of portal vein thrombosis in patients with underlying liver cirrhosis, but without co-incident hepatocellular carcinoma, is between 10-18% with an annual incidence between 4-24% 17,18."
"The demographics of patients with portal venous thrombosis will match those of the underlying condition. The prevalence of portal vein thrombosis in patients with underlying liver cirrhosis, but without co-incident hepatocellular carcinoma, is between 10-18% with an annual incidence between 4-24% 17,18."
"suggested optimal cutoff value: max SUV 2.3-3.6 8,11"
"management of portal hypertension (beta-blockers, diuretics, and TIPS)"
Expected headings
"Dual energy CT"
"PET-CT"